Characterization of four clones derived from human adenocarcinoma cell line, HT29, and analysis of their response to sodium butyrate

International Journal of Oncology

Volumn 28, Issue 2, 2006, Pages 559-565

  Stokrová, Jitka ^a   Sloncová, Eva ^a   Sovová, Vlasta ^a   Kucerová, Dana ^a   Zíla, Vojtech ^a   Turecková, Jolana ^a   Vojtechová, Martina ^a   Korb, Jan ^a   Tuhácková, Zdena ^a  

^a INSTITUTE OF MATHEMATICS   (Czech Republic)

Author keywords

Adenocarcinoma; Apoptosis; Cell clones; Differentiation; HT29 cell line; Sodium butyrate; Ultrastructure

Indexed keywords

ALKALINE PHOSPHATASE; BUTYRIC ACID DERIVATIVE; CD66 ANTIGENS; CELL ADHESION MOLECULE; LEUKOCYTE ANTIGEN; MITOGEN ACTIVATED PROTEIN KINASE P38;

ADENOCARCINOMA; APOPTOSIS; ARTICLE; CELL CLONE; CELL DIFFERENTIATION; CELL STRAIN HT29; COLORECTAL TUMOR; DRUG EFFECT; HUMAN; METABOLISM; PATHOLOGY; ULTRASTRUCTURE;

ADENOCARCINOMA; ALKALINE PHOSPHATASE; ANTIGENS, CD; APOPTOSIS; BUTYRATES; CELL ADHESION MOLECULES; CELL DIFFERENTIATION; CLONE CELLS; COLORECTAL NEOPLASMS; HT29 CELLS; HUMANS; P38 MITOGEN-ACTIVATED PROTEIN KINASES;

EID: 39049180196     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.28.2.559     Document Type: Article

References (23)

1. Le Bivic A, Hirn M and Reggio H: HT-29 cells are an in vitro model for the generation of cell polarity in epithelia during embryonic differentiation. Proc Natl Acad Sci USA 85: 136-140, 1988.
2. Kruh J: Effects of sodium butyrate, a new pharmacological agent, on cells in culture. Mol Cell Biochem 42: 65-82, 1982.
3. Schroy PC, Rustgi AK, Ikonomu E, Liu XP, Polito J, Andry C, and O'Keane JC: Growth and intestinal differentiation are independently regulated in HT29 colon cancer cells. J Cell Physiol 161: 111-123, 1994.
4. Kucerová D, Stokrová J, Korb J, Sloncová E, Tuhácková Z and Sovová V: Response of HT29 cells to butyrate depends on time of exposure and glucose deprivation. Int J Mol Med 10: 779-784, 2002.
5. Pinto M, Appay MD, Simon-Assmann P, Chevalier G, Dracopoli N, Fogh J and Zweibaum A: Enterocytic differentiation of cultured human colon cancer cells by replacement of glucose by galactose in the medium. Biol Cell 44: 193-196, 1982.
6. Soergel KH: Colonic fermentation: metabolic and clinical implications. Clin Investig 72: 742-748, 1994.
7. Emanuele S, D'Anneo A, Bellavia G, Vassallo B, Lauricella M, De Blasio A, Vento R and Tesoriere G: Sodium butyrate induces apoptosis in human hepatoma cells by a mitochondria/caspase pathway, associated with degradation of beta-catenin, pRb and Bcl-XL. Eur J Cancer 40: 1441-1452, 2004.
8. Hafez MM, Infante D, Winawer S and Friedman E: Transforming growth factor beta 1 acts as an autocrine-negative growth regulator in colon enterocytic differentiation but not in goblet cell maturation. Cell Growth Differ 1: 617-626, 1990.
9. Zweibaum A, Pinto M, Chevalier G, Dussaulx E, Triadou N, Lacroix B, Haffen K, Brun JL and Rousset M: Enterocytic differentiation of a subpopulation of the human colon tumor cell line HT-29 selected for growth in sugar-free medium and its inhibition by glucose. J Cell Physiol 122: 21-29, 1985.
10. Laboisse CL, Maoret JJ, Triadou N and Augeron C: Restoration by polyethylene glycol of characteristics of intestinal differentiation in subpopulations of the human colonic adenocarcinoma cell line HT29. Cancer Res 48: 2498-2504, 1988.
11. Augeron C and Laboisse CL: Emergence of permanently differentiated cell clones in a human colonic cancer cell line in culture after treatment with sodium butyrate. Cancer Res 44: 3961-3969, 1984.
12. Lesuffleur T, Barbat A, Dussaulx E and Zweibaum A: Growth adaptation to methotrexate of HT-29 human colon carcinoma cells is associated with their ability to differentiate into columnar absorptive and mucus-secreting cells. Cancer Res 50: 6334-6343, 1990.
13. Sovová V, Stokrová J, Sloncová E, Kucerová D, Tuhácková Z and Korb J: Alterations in mitochondria function and morphology in HT29 cells upon conditions inducing differentiation and apoptosis. Int J Oncol 23: 1755-1760, 2003.
14. Dráberová L, Stanners CP and Dráber P: A novel monoclonal antibody specific for biliary glycoprotein (CD66a). Folia Biol (Praha) 43: 243-244, 1997.
15. Richterová Z, Liebl D, Horák M, Palková Z, Stokrová J, Hozák P, Korb J, Forstová J: Caveolae are involved in the trafficking of mouse polyomavirus virions and artificial VP1 pseudocapsids toward cell nuclei. J Virol 75: 10880-10891, 2001.
16. Tanaka K, Hinoda Y, Takahashi H, Sakamoto H, Nakajima Y and Imai K: Decreased expression of biliary glycoprotein in hepatocellular carcinomas. Int J Cancer 74: 15-19, 1997.
17. Raingeaud J, Gupta S, Rogers JS, Dickens M, Han J, Ulevitch RJ and Davis RJ: Pro-inflammatory cytokines and environmental stress cause p38 mitogen-activated protein kinase activation by dual phosphorylation on tyrosine and threonine. J Biol Chem 270: 7420-7426, 1995.
18. Yosimichi G, Nakanishi T, Nishida T, Hattori T, Takano-Yamamoto T and Takigawa M: CTGF-Hcs24 induces chondrocyte differentiation through a p38 mitogen-activated protein kinase (p38 MAPK), and proliferation through a p44/42 MAPK/extracellular-signal regulated kinase (ERK). Eur J Biochem 268: 6058-6065, .
19. Phillips TE, Huet C, Bilbo PR, Podolsky DK, Louvard D and Neutra MR: Human intestinal goblet cells in monolayer culture: characterization of a mucus-secreting subclone derived from the HT29 colon adenocarcinoma cell line. Gastroenterology 94: 1390-1403, 1988.
20. Sundberg U, Beauchemin N and Obrink B: The cytoplasmic domain of CEACAM1-L controls its lateral localization and the organization of desmosomes in polarized epithelial cells. J Cell Sci 117: 1091-104, 2004.
21. Tan S, Seow TK, Liang RC, Koh S, Lee CP, Chung MC and Hooi SC: Proteome analysis of butyrate-treated human colon cancer cells (HT-29). Int J Cancer 98: 523-531, 2002.
22. Wakabayashi T: Megamitochondria formation - physiology and pathology. J Cell Mol Med 6: 497-538, 2002.
23. Huet C, Sahuquillo-Merino C, Coudrier E and Louvard D: Absorptive and mucus-secreting subclones isolated from a multipotent intestinal cell line (HT-29) provide new models for cell polarity and terminal differentiation. J Cell Biol 105: 345-357, 1987.